HER Specific TKIs Exert Their Antineoplastic Effects on Breast Cancer Cell Lines through the Involvement of STAT5 and JNK. [electronic resource]
Producer: 20160706Description: e0146311 p. digitalISSN:- 1932-6203
- Afatinib
- Antineoplastic Agents -- pharmacology
- Apoptosis
- Breast Neoplasms -- drug therapy
- Cell Line, Tumor
- Cell Proliferation
- Drug Resistance, Neoplasm
- Drug Screening Assays, Antitumor
- ErbB Receptors -- antagonists & inhibitors
- Female
- Humans
- Inhibitory Concentration 50
- JNK Mitogen-Activated Protein Kinases -- metabolism
- Lapatinib
- MAP Kinase Signaling System
- Morpholines -- pharmacology
- Phosphorylation
- Protein Kinase Inhibitors -- pharmacology
- Protein Processing, Post-Translational
- Quinazolines -- pharmacology
- STAT5 Transcription Factor -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.